Skip to content

Feed Screener Search MCP Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Mathieu Charvériat — THX PHARMA insider: 1 transactions · InsiderLens

Feed Screener Search MCP Methodology

Pricing Sign in

Home / Insiders / Mathieu Charvériat

Mathieu Charvériat

CEO at THX PHARMA · on record since Mar 30, 2026

Insider trading activity of Mathieu Charvériat

Transactions on record: 1; since Mar 30, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 30, 2026

Figures computed from official regulatory filings — methodology.

Companies where Mathieu Charvériat has traded

THX PHARMA1 tx · Mar 30, 2026

Track record of Mathieu Charvériat

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Mathieu Charvériat

Co-insiders of Mathieu Charvériat

JULIEN VEYSTHX PHARMA

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
THX PHARMA	Mar 30, 2026	Exercise	22,436	3.02 EUR	—	AMF